description
Functional Validation of miRNA Gene Targets
product line
MISSION®
concentration
≥1x105 VP/ml (via p24 assay)
human 3′UTR sequence
ACTGCCTACAAGAGCTGCTTCATGAGTAGAAATTTCAACAACTCTTTTTGAATGTATGAAGAGTAGCAGTCCCCTTTGGATGTCCAAGTTATATGTGTCTAGATTTTGATTTCATATATATGTGTATGGGAGGCATGGATATGTTATGAAATCAGCTGGTAATTCCTCCTCATCACGTTTCTCTCATTTTCTTTTGTTTTCCATTGCAAGGGGATGGTTGTTTTCTTTCTGCCTTTAGTTTGCTTTTGCCCAAGG (3′UTR sequences are truncated after the first 255 bases)
NCBI accession no.
shipped in
dry ice
storage temp.
−70°C
Gene Information
human ... PROX1(5629)
Application
To see more application data, protocols, and vector maps visit www.sigma.com/3utr.
Physical form
200 μL of at least 105 VP/mL (via p24 titering assay) lentiviral particles are provided as frozen stock.
Legal Information
Use of this product is subject to one or more license agreements. For details, please see www.sigmaaldrich.com/missionlicense.
GoClone is a trademark of SwitchGear Genomics
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
SwitchGear Genomics is a trademark of SwitchGear Genomics
存储类别
12 - Non Combustible Liquids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Minkoo Seo et al.
Journal of biomedical science, 22, 3-3 (2015-01-13)
Lymphangiogenesis is one of the major causes of corneal graft rejection. Among the lymphangiogenic factors, vascular endothelial growth factor (VEGF)-C and -D are considered to be the most potent. Both bind to VEGF receptor 3 (VEGFR3) to activate Prospero homeobox
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持